Free radical theory of aging: Alzheimer’s disease pathogenesis
暂无分享,去创建一个
[1] C. Duyckaerts,et al. Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person , 1990, Neuroscience Letters.
[2] S. Younkin,et al. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.
[3] G K Wilcock,et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[4] G. V. Van Hoesen,et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.
[5] M. L. Schmidt,et al. An extensive network of PHFτ‐rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease , 1994, FEBS letters.
[6] Robert Hill,et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.
[7] S. Prusiner,et al. Molecular biology of prion diseases , 1991, Science.
[8] M. Mattson,et al. β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .
[9] P. Moran,et al. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[11] Carl W. Cotman,et al. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[12] D. Melton,et al. Vertebrate embryonic induction: mesodermal and neural patterning. , 1994, Science.
[13] R. Godwin-Austen,et al. DIFFUSE LEWY BODY DISEASE: AN IMPORTANT DIFFERENTIAL DIAGNOSIS IN DEMENTIA WITH EXTRAPYRAMIDAL FEATURES , 1989, Progress in clinical and biological research.
[14] N Butters,et al. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. , 1994, Archives of neurology.
[15] D. Hegner,et al. Mitochondrial formation of OH Radicals by an ubisemiquinone-dependent reaction an alternative pathway to the iron-catalysed Haber-Weiss cycle. , 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[16] B. Chance,et al. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Orrenius,et al. Role of calcium in toxic and programmed cell death. , 1991, Advances in experimental medicine and biology.
[18] A. Scheibel,et al. A Reexamination of Aluminum in Alzheimer's Disease: Analysis by Energy Dispersive X-ray Microprobe and Flameless Atomic Absorption Spectrophotometry , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[19] M. Mesulam,et al. β-Amyloid and the pathogenesis of alzheimer's disease , 1991 .
[20] S. Orrenius,et al. Role of Ca2+ in toxic cell killing. , 1989, Trends in pharmacological sciences.
[21] T. Ozawa,et al. Age-associated damage in mitochondrial DNA in human hearts , 1993, Molecular and Cellular Biochemistry.
[22] C. Behl,et al. Amyloid peptides are toxic via a common oxidative mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Behl,et al. Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.
[24] Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[25] T. Molitor,et al. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.
[26] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[27] J. Ordy,et al. Free radical theory of aging: Effect of dietary lipids on lipofuscin accumulation in the hippocampus of rats , 2006, AGE.
[28] R. Katzman.,et al. Advances in Alzheimer's disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] D. Neary,et al. Metabolic Processes in Alzheimer's Disease: Adenine Nucleotide Content and Production of 14CO2 from [U‐14C]Glucose In Vitro in Human Neocortex , 1983, Journal of neurochemistry.
[30] C. Cotman,et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Martins,et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.
[32] L. Rowland. Mitochondrial encephalomyopathies: lumping, splitting and melding , 1994 .
[33] J. Bogaard,et al. NADH-CoQ REDUCTASE DEFICIENT MYOPATHY: SUCCESSFUL TREATMENT WITH RIBOFLAVIN , 1983, The Lancet.
[34] K. Miyoshi,et al. Degeneration of neuronal processes in rats induced by a protease inhibitor, leupeptin , 2004, Acta Neuropathologica.
[35] J. Hickman,et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. , 1993, The EMBO journal.
[36] P. Mantyh,et al. Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide , 1993, Journal of neurochemistry.
[37] K. Davis,et al. Age-dependent expression of familial risk in Alzheimer's disease. , 1988, American journal of epidemiology.
[38] C. Cotman,et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.
[39] David M. A. Mann,et al. The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations , 1985, Mechanisms of Ageing and Development.
[40] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[41] J. M. Anderson,et al. SEX DIFFERENCES IN AGE-RELATED BRAIN ATROPHY , 1983, The Lancet.
[42] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[43] J. Cleveland,et al. Contenders in FasL/TNF death signaling , 1995, Cell.
[44] R. S. Sohal,et al. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse , 1994, Mechanisms of Ageing and Development.
[45] R. Nixon,et al. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Landin,et al. Ultrastructure of skeletal muscle in patients with Parkinson's disease and upper motor lesions. , 1975, Laboratory investigation; a journal of technical methods and pathology.
[47] D. Ferrari,et al. Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.
[48] F. Zemlan,et al. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation , 1989, Brain Research.
[49] B. Hyman,et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.
[50] V. Meininger,et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.
[51] L. Isenman,et al. Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation. , 1989, The Journal of biological chemistry.
[52] A. Roses,et al. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.
[53] R. Sutton,et al. β-BLOCKERS, AUTOIMMUNITY, AND RASHES , 1980, The Lancet.
[54] M. Mattson,et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[55] S. Younkin. Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .
[56] G WhittakerP,et al. 共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値 , 1980 .
[57] F. Tagliavini,et al. Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques , 1989, Neuroscience Letters.
[58] T. Molitor,et al. Neuroprotective role of IL-4 against activated microglia. , 1993, Journal of immunology.
[59] E. Stopa,et al. Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain , 1995, Annals of neurology.
[60] E. Janzen. A Critical Review of Spin Trapping in Biological Systems , 1980 .
[61] D. Wallace,et al. Oxidative Phosphorylation Diseases , 1990 .
[62] E. Masliah,et al. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease , 1989, Neuroscience Letters.
[63] N. Khansari,et al. Immunological dysfunction in Alzheimer's disease , 1985, Journal of Neuroimmunology.
[64] Sangkot Marzuki,et al. MITOCHONDRIAL DNA MUTATIONS AS AN IMPORTANT CONTRIBUTOR TO AGEING AND DEGENERATIVE DISEASES , 1989, The Lancet.
[65] E. Stadtman. Protein oxidation and aging. , 1992, Free radical research.
[66] E. Masliah,et al. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. , 1990, The American journal of pathology.
[67] H. Wiśniewski,et al. Morphology of the aging brain, human and animal. , 1973, Progress in brain research.
[68] J. Weber,et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.
[69] S. Yamashita,et al. Mitochondrial DNA and human thyroid diseases. , 2004, Endocrine journal.
[70] J. Reed,et al. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .
[71] T D Koepsell,et al. The association between head trauma and Alzheimer's disease. , 1990, American journal of epidemiology.
[72] E. Mandelkow,et al. The Alzheimer‐like phosphorylation of tau protein reduces microtubule binding and involves Ser‐Pro and Thr‐Pro motifs , 1992, FEBS letters.
[73] H. Wiśniewski,et al. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION: 1. LIGHT MICROSCOPIC OBSERVATIONS , 1965, Journal of neuropathology and experimental neurology.
[74] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[75] E M Wijsman,et al. A familial Alzheimer's disease locus on chromosome 1 , 1995, Science.
[76] C. Barrow,et al. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.
[77] Denham Harman,et al. The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.
[78] T. Ozawa,et al. Hypothesis. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases , 1989 .
[79] K. Kosik,et al. Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.
[80] G. Schellenberg,et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.
[81] S. Hirai,et al. Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: comparison with primitive plaques , 2004, Acta Neuropathologica.
[82] H. Braak,et al. Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[83] K. Ikeda,et al. Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells , 1993, Brain Research.
[84] D. Wallace. Mitochondrial genetics: a paradigm for aging and degenerative diseases? , 1992, Science.
[85] D. Johns. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. , 1995, The New England journal of medicine.
[86] P. Frost,et al. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. , 1992, Age and ageing.
[87] Edward Byrne,et al. DECLINE IN SKELETAL MUSCLE MITOCHONDRIAL RESPIRATORY CHAIN FUNCTION: POSSIBLE FACTOR IN AGEING , 1989, The Lancet.
[88] S. Dimauro,et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. , 1989, The New England journal of medicine.
[89] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[90] S. Lipton,et al. Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.
[91] Y. Wei,et al. Liver mitochondrial respiratory functions decline with age. , 1989, Biochemical and biophysical research communications.
[92] J. Connor,et al. Aluminum access to the brain: a role for transferrin and its receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[93] M J Ball,et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.
[94] D. Shibata,et al. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[95] V. Yong,et al. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease , 1987, Annals of neurology.
[96] D. Mann,et al. Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar? , 1993, The American journal of pathology.
[97] M. Waldrop. New Light on Dark Matter?: It fills the universe, it is utterly invisible, and it may not even exist; meanwhile, the hypotheses are getting more exotic. , 1984, Science.
[98] J Lejeune,et al. Trisomy 21 (Down's syndrome). Glutathione peroxidase, hexose monophoshate shunt and I.Q. , 1979, Life sciences.
[99] G. Lynch,et al. Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. , 1984, Science.
[100] B. Yankner,et al. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[101] R. Katzman.,et al. Alzheimer Disease: Basic and Clinical Advances , 1991, Journal of the American Geriatrics Society.
[102] R Luft,et al. The development of mitochondrial medicine. , 1995, Biochimica et biophysica acta.
[103] A. Guterman,et al. Neurological Sequelae of Boxing , 1987, Sports medicine.
[104] D. Kerr,et al. BRAIN-ALUMINIUM CONCENTRATION IN DIALYSIS ENCEPHALOPATHY , 1978, The Lancet.
[105] R. Tyrrell,et al. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. , 1991, Cancer research.
[106] D. Selkoe,et al. Amyloid protein and Alzheimer's disease. , 1991, Scientific American.
[107] J. Sulston,et al. The embryonic cell lineage of the nematode Caenorhabditis elegans. , 1983, Developmental biology.
[108] J. Rogers,et al. Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease , 1992, Neurology.
[109] R. Salgia,et al. Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts. Kinetic evidence that the transfer of proteins to lysosomes is not irreversible. , 1987, The Journal of biological chemistry.
[110] W. D. Kaehny,et al. The dialysis encephalopathy syndrome. Possible aluminum intoxication. , 1976, The New England journal of medicine.
[111] Yasuo Ihara,et al. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.
[112] M. Swash,et al. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity. , 1987, Clinical neuropathology.
[113] E. Stopa,et al. Basic fibroblast growth factor in Alzheimer's disease. , 1990, Biochemical and biophysical research communications.
[114] H. Häfner. Epidemiology of Alzheimer’s disease , 1990 .
[115] G. Drewes,et al. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro , 1992, The Journal of cell biology.
[116] B. L. Walker. Maternal diet and brain fatty acids in young rats , 1967, Lipids.
[117] P. O. Ganrot. Metabolism and possible health effects of aluminum. , 1986, Environmental health perspectives.
[118] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[119] B. Hyman,et al. Alzheimer's mutation , 1991, Nature.
[120] A. Himmler. Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family , 1989, Molecular and cellular biology.
[121] M. Kirschner,et al. Tau protein binds to microtubules through a flexible array of distributed weak sites , 1991, The Journal of cell biology.
[122] D. Price,et al. Age‐Dependent Impairment of Mitochondrial Function in Primate Brain , 1993, Journal of neurochemistry.
[123] S. Little,et al. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. , 1991, Brain research. Molecular brain research.
[124] D. Harman. Aging: Prospects for further increases in the functional life span , 1994, AGE.
[125] A. Tappel,et al. Measurement and spectral characteristics of fluorescent pigments in tissues of rats as a function of dietary polyunsaturated fats and vitamin E. , 1973, The Journal of nutrition.
[126] Hans Lassmann,et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ , 2004, Acta Neuropathologica.
[127] E. Stadtman. Oxidation of proteins by mixed-function oxidation systems: implication in protein turnover, ageing and neutrophil function , 1986 .
[128] L. Wolfson,et al. Clinico‐pathologic studies in dementia , 1988, Neurology.
[129] H. Brewer,et al. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.
[130] D. Sherrard. Aluminum--much ado about something. , 1991, The New England journal of medicine.
[131] J. A. V Pritchard,et al. CANCER DETECTION , 1976, The Lancet.
[132] W. D. de Grip,et al. Alzheimer's disease and cellular aging: membrane-related events as clues to primary mechanisms. , 1991, Gerontology.
[133] C. Cotman,et al. Lipid composition of synaptic plasma membranes isolated from rat brain by zonal centrifugation. , 1969, Biochemistry.
[134] R. Nixon,et al. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[135] S. Cadenas,et al. Low mitochondrial free radical production per unit O2 consumption can explain the simultaneous presence of high longevity and high aerobic metabolic rate in birds. , 1994, Free radical research.
[136] P. Fraser,et al. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain , 1994, Neuron.
[137] Y. Tamai,et al. Lipid composition of nerve cell perikarya , 1971 .
[138] C. W. Scott,et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[139] B. Hyman,et al. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. , 1994, The American journal of pathology.
[140] C. W. Adams,et al. The cerebral vasculature in dementia pugilistica. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[141] E. Masliah,et al. Protein kinase C alteration is an early biochemical marker in Alzheimer's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[142] H. Steller. Mechanisms and genes of cellular suicide , 1995, Science.
[143] D. Harman. Free radical involvement in aging. Pathophysiology and therapeutic implications. , 1993, Drugs & aging.
[144] P. Cohen,et al. p42 map kinase phosphorylation sites in microtubule‐associated protein tau are dephosphorylated by protein phosphatase 2A1 Implications for Alzheimer's disease , 1992, FEBS letters.
[145] Z. Oltvai,et al. Checkpoints of dueling dimers foil death wishes , 1994, Cell.
[146] J. H. Stekhoven,et al. Exogenous aluminum accumulates in the lysosomes of cultured rat cortical neurons , 1990, Neuroscience Letters.
[147] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[148] P. Starke-Reed,et al. Protein oxidation and proteolysis during aging and oxidative stress. , 1989, Archives of biochemistry and biophysics.
[149] H. Wiśniewski,et al. An Experimental Approach to the Morphogenesis of Neurofibrillary Degeneration and the Argyrophilic Plaque , 2008 .
[150] D. Selkoe,et al. Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.
[151] J. Kimura,et al. Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. , 1995, The American journal of pathology.
[152] W. Lukiw,et al. WOULD DECREASED ALUMINIUM INGESTION REDUCED THE INCIDENCE OF ALZHEIMER'S DISEASE ? , 1991 .
[153] B. Crain,et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.
[154] B. Regland,et al. The role of amyloid β-protein in Alzheimer's disease , 1992, The Lancet.
[155] J. Goldman,et al. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[156] H. Wiśniewski,et al. Neuropathology of the Aging Brain and Dementia of the Alzheimer Type , 1985 .
[157] V. Hachinski,et al. A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIA , 1985, The Lancet.
[158] R. S. Sohal,et al. Hydrogen peroxide release by mitochondria increases during aging , 1991, Mechanisms of Ageing and Development.
[159] S. Yen,et al. Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments , 1992, Brain Research.
[160] R. Dean. A mechanism for accelerated degradation of intracellular proteins after limited damage by free radicals , 1987, FEBS letters.
[161] R. Katzman.,et al. Alzheimer's disease. , 1986, The New England journal of medicine.
[162] T. Arendt,et al. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in alzheimer's disease , 1985, Neuroscience.
[163] J. Blass,et al. Systemic manifestations of Alzheimer’s disease , 1988, AGE.
[164] D. Harman. Free radical theory of aging: Consequences of mitochondrial aging , 1983, AGE.
[165] J. Cooper,et al. Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA , 1989, Annals of neurology.
[166] J. Nalbantoglu,et al. Genetic Factors in Alzheimer's Disease , 1990, Journal of the American Geriatrics Society.
[167] J. Miquel,et al. Is cell aging caused by respiration-dependent injury to the mitochondrial genome? , 1982, Gerontology.
[168] B. Strooper,et al. α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease , 1993, Neurobiology of Aging.
[169] C. Marsden,et al. Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.
[170] S. Orrenius,et al. The role of Ca2+ in cell killing. , 1990, Chemical research in toxicology.
[171] R. Nixon,et al. The Lysosomal System in Neurons , 1992 .
[172] R. Nixon,et al. Free radicals, proteolysis, and the degeneration of neurons in alzheimer disease: How essential is the β-amyloid link? , 1994, Neurobiology of Aging.
[173] M. Paula-Barbosa,et al. ALZHEIMER'S DISEASE: PAIRED HELICAL FILAMENTS AND CYTOMEMBRANES , 1987, Neuropathology and applied neurobiology.
[174] D. Harman,et al. Free Radical Theory of Aging: Effect of Age, Sex and Dietary Precursors on Rat‐Brain Docosahexanoic Acid † , 1977, Journal of the American Geriatrics Society.
[175] P. Lansbury,et al. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[176] J. M. Blumberg,et al. AN ELECTRON MICROSCOPIC STUDY OF DYSTROPHIC AXONS IN THE GRACILE AND CUNEATE NUCLEI OF VITAMIN E‐DEFICIENT RATS , 1964, Journal of neuropathology and experimental neurology.
[177] D. Hegner,et al. Do mitochondria produce oxygen radicals in vivo? , 1978, European journal of biochemistry.
[178] C Oliver,et al. Down's Syndrome and Alzheimer's disease: a review , 1986, Psychological Medicine.
[179] R. DeTeresa,et al. Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.
[180] L. Packer,et al. Surface localization of sites of reduction of nitroxide spin-labeled molecules in mitochondria. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[181] D. Brems,et al. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. , 1994, Molecular pharmacology.
[182] D. Selkoe,et al. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.
[183] O. Elroy-Stein,et al. Overproduction of human Cu/Zn‐superoxide dismutase in transfected cells: extenuation of paraquat‐mediated cytotoxicity and enhancement of lipid peroxidation. , 1986, The EMBO journal.
[184] R. Martins,et al. Increased Cerebral Glucose‐6‐Phosphate Dehydrogenase Activity in Alzheimer's Disease May Reflect Oxidative Stress , 1986, Journal of neurochemistry.
[185] R. A. Crowther,et al. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.
[186] C. Masters,et al. The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. , 1981, Brain : a journal of neurology.
[187] S. Prusiner,et al. Etiology and pathogenesis of prion diseases. , 1995, The American journal of pathology.
[188] A. Harding. Neurological disease and mitochondrial genes , 1991, Trends in Neurosciences.
[189] D. Wallace,et al. Heart disease and mitochondrial DNA mutations. , 1992, Heart disease and stroke : a journal for primary care physicians.
[190] J. Lowe,et al. Protein processing in lysosomes: the new therapeutic target in neurodegenerative disease , 1992, The Lancet.
[191] K. Yoshikawa,et al. Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor , 1992, Nature.
[192] J. Merrill,et al. Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[193] K. Boje,et al. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death , 1992, Brain Research.
[194] P. Lebon,et al. Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions , 1988, Journal of the Neurological Sciences.
[195] D. Selkoe,et al. Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. , 1993, The American journal of pathology.
[196] D. Selkoe,et al. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.
[197] M. Beal,et al. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[198] J. Growdon,et al. Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[199] K. Beyreuther,et al. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.
[200] R. Tanzi,et al. Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.
[201] B. Hyman,et al. The Lack of Accumulation of Senile Plaques or Amyloid Burden in Alzheimer's Disease Suggests a Dynamic Balance Between Amyloid Deposition and Resolution , 1993, Journal of neuropathology and experimental neurology.
[202] M. Kirschner,et al. Phosphorylation of microtubule‐associated protein tau: identification of the site for Ca2(+)‐calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. , 1990, The EMBO journal.
[203] S. L'Hernault,et al. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions , 1992, The Journal of cell biology.
[204] S. Estus,et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.
[205] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[206] B. Ghetti,et al. Alzheimer patients: preamyloid deposits are more widely distributed than senile plaques throughout the central nervous system , 1989, Neuroscience Letters.
[207] D. Harman. Free radical theory of aging. , 1992, Triangle; the Sandoz journal of medical science.
[208] R. Weindruch,et al. Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. , 1993, Journal of gerontology.
[209] M. Crawford,et al. Nutritional influences in the evolution of mammalian brain. In: lipids, malnutrition & the developing brain. , 1971, Ciba Foundation symposium.
[210] K. Davies. Protein damage and degradation by oxygen radicals. I. general aspects. , 1987, The Journal of biological chemistry.
[211] J. Ávila,et al. Tau factor polymers are similar to paired helical filaments of Alzheimer's disease , 1988, FEBS letters.
[212] Furnass Sb. Seminal vitamin B-12 and sterility. , 1963 .
[213] R. Nixon,et al. Aluminum salts induce the accumulation of neurofilaments in perikarya of NB2a/dl neuroblastoma , 1989, Brain Research.
[214] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[215] O. Elroy-Stein,et al. Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dimutase-implication for gene dosage effects in down syndrome , 1988, Cell.
[216] G. Cole,et al. Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .
[217] Yves Agid,et al. Parkinson's disease: pathophysiology , 1991, The Lancet.
[218] D. Allsop,et al. The occult aftermath of boxing. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[219] S. Yorifuji,et al. Treatment of Kearns‐Sayre syndrome with coenzyme Q10 , 1986, Neurology.
[220] Margaret A. Pericak-Vance,et al. Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype , 1994, Experimental Neurology.
[221] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[222] C. Filley,et al. Cytochrome oxidase deficiency in Alzheimer's disease , 1990, Neurology.
[223] R. Bucala,et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[224] R. Friede. The relation of the formation of lipofuscin to the distribution of oxidative enzymes in the human brain , 2004, Acta Neuropathologica.
[225] H. Wiśniewski,et al. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. , 1992, Biochemical and biophysical research communications.
[226] M. Tabaton,et al. Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease. , 1992, The American journal of pathology.
[227] Bradley T. Hyman,et al. Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.
[228] W. Lukiw,et al. Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? , 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[229] R. S. Sohal,et al. Comparison of mitochondrial pro-oxidant generation and anti-oxidant defenses between rat and pigeon: possible basis of variation in longevity and metabolic potential , 1993, Mechanisms of Ageing and Development.
[230] A. Cataldo,et al. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[231] D. Turnbull,et al. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease , 1991, Journal of the Neurological Sciences.
[232] B. Bowerman. Determinants of blastomere identity in the early C. elegans embryo , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[233] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[234] H. Braak,et al. Morphology of the cerebral cortex in relation to Alzheimer’s dementia , 1989 .
[235] E. Stadtman,et al. Covalent modification reactions are marking steps in protein turnover. , 1990, Biochemistry.
[236] M. Goedert,et al. Risky apolipoprotein in brain , 1994, Nature.
[237] T. Iwatsubo,et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.
[238] D. Harman. Free Radical Involvement in Aging , 1993 .
[239] D. Graham,et al. βA4 amyloid protein deposition in brain after head trauma , 1991, The Lancet.
[240] W. D. Ehmann,et al. Laser microprobe analysis of brain aluminum in Alzheimer' disease , 1993, Annals of neurology.
[241] D. Harman,et al. Free radical theory of aging: Beneficial effect of adding antioxidants to the maternal mouse diet on life span of offspring; possible explanation of the sex difference in longevity , 1979, AGE.
[242] G. Perry,et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.
[243] L. Higgins,et al. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[244] B. I. Roots. Neurofilament accumulation induced in synapses by leupeptin. , 1983, Science.
[245] M. Sagai,et al. Age-related changes in lipid peroxidation as measured by ethane, ethylene, butane and pentane in respired gases of rats. , 1980, Life sciences.
[246] E. Stadtman,et al. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. , 1990, Free radical biology & medicine.
[247] C. Behl,et al. Amyloid β peptide induces necrosis rather than apoptosis , 1994, Brain Research.
[248] R. S. Sohal,et al. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. , 1993, Free radical biology & medicine.
[249] C Osmond,et al. GEOGRAPHICAL RELATION BETWEEN ALZHEIMER'S DISEASE AND ALUMINIUM IN DRINKING WATER , 1989, The Lancet.
[250] N. Cairns,et al. Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.
[251] E. Stadtman,et al. Metal-catalyzed oxidation of proteins. Physiological consequences. , 1991, The Journal of biological chemistry.
[252] S. Prusiner,et al. Prions and neurodegenerative diseases. , 1987, The New England journal of medicine.
[253] C. Thompson,et al. Apoptosis in the pathogenesis and treatment of disease , 1995, Science.
[254] R. Gregg,et al. Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.
[255] L. Lovat,et al. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[256] R. Terry,et al. ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. , 1964, The American journal of pathology.
[257] S. Orrenius,et al. Cytoskeletal alterations in human platelets exposed to oxidative stress are mediated by oxidative and Ca2+-dependent mechanisms. , 1989, Archives of biochemistry and biophysics.
[258] B. Hyman,et al. Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? , 1993, Trends in Neurosciences.
[259] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[260] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[261] R. Lyman,et al. Evidence for nonessentiality of linolenic acid in the diet of the rat. , 1971, The Journal of nutrition.
[262] S. DeKosky,et al. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.
[263] Khadija Iqbal,et al. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. , 1993, Archives of biochemistry and biophysics.
[264] D. Harman,et al. Lipofuscin and ceroid formation: the cellular recycling system. , 1989, Advances in experimental medicine and biology.
[265] D. Mann,et al. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.
[266] D. Mann,et al. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.
[267] A. Davison,et al. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? , 1990, Free radical biology & medicine.